Browse
Submit Data
Databases
API
Help

Dataset Information

18 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pandemic response management framework based on efficiency of COVID-19 control and treatment

ABSTRACT: Aims: The existing response management system for pandemic disease fell short of controlling COVID-19. This study evaluates the response management relative efficiency of 58 countries in two stages, using two models. Materials & methods: Data envelopment analysis was applied for efficiency analysis. Results: 89.6% of countries were inefficient in pandemic control and 79% were inefficient in treatment measures. Sensitivity analysis underlines resources as a critical factor. Further examination points to absence of a robust and uniform mitigation measure against the pandemic in most countries. Conclusions: Preventing spread is not only the first line of defense; it is the only line of defense. The lack of a global public health database support system and uniform response compounded inefficiency. A robust pandemic response management framework is developed based on practices of key performers. Action plans are proposed, with a recommendation for a global public health pandemic database monitoring and support system as the nucleus. Graphical abstract

SUBMITTER: Ibrahim M

PROVIDER: S-EPMC7740003 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Efficiency analysis in the management of COVID-19 pandemic in India based on data envelopment analysis

Project description:Purpose: This article measured the performance of 32 states and union territories (UTs) of India against COVID-19 disease using efficiency score which was calculated by data envelopment analysis (DEA) and compared the efficiency score with the different models which are used in many articles to evaluate the efficiency of healthcare system. Here the input parameters are taken as public health expenditure in a million, number of hospitals, number of hospital beds, percentage of health workers, population density, and number of infected, and output parameters divided into good and bad categories such as the number of recovered are taken as good output. The number of death is taken as bad outputs. The modified undesirable output model is used to calculate efficiency score and compared the efficiency score with Charnes, Cooper, and Rhodes (CCR) and Banker, Charnes, and Cooper (BCC) models. Finally, the states & UTs are completely ranked with the help of efficiency score and Maximal Balance Index, and evaluated benchmarking for each states & UTs. Data Source: Secondary data were collected from Census 2011 and the Ministry of health & family welfare, Government of India on 32 stats & UTs (NHAC, 2018; NHP, 2019; COVID19India, 2021). Results: According to Undesirable model results, 16 (50%) of 32 Indian states & UTs s were found to be efficient. Among the efficient DMUs, Chandigarh is the most efficient unit and Meghalaya is the most inefficient unit. Rajasthan was the most referenced state for inefficient states. Limitation: The efficiency score is affected by changing the number of inputs and outputs. The lack of more effective parameters are used to evaluate performance and enable qualitative variable comparison.

| S-EPMC8556177 | biostudies-literature

Physical activity and mental health during the COVID-19 pandemic among individuals with amputation

Project description: Not available

| S-BSST1055 | biostudies-other

Collaborative Response to COVID-19 Pandemic, and Development of Treatment Guidelines.

Project description: Not available

| S-EPMC8032908 | biostudies-literature

Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies.

Project description:Following the emergence of severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012, the world is now combating a third large-scale outbreak caused by a coronavirus, the coronavirus disease 2019 (COVID-19). After the rapid spread of SARS-coronavirus (CoV)-2 (the virus causing COVID-19) from its origin in China, the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) on January 30, 2020. From the beginning of the COVID-19 pandemic, a significant number of studies have been conducted to better understand the biology and pathogenesis of the novel coronavirus, and to aid in developing effective treatment regimens, therapeutics, and vaccines. This review focuses on the recent advancements in the rapidly evolving areas of clinical care and management of COVID-19. The emerging strategies for the diagnosis and treatment of this disease are explored, and the development of effective vaccines is reviewed.

| S-EPMC7883285 | biostudies-literature

A control framework to optimize public health policies in the course of the COVID-19 pandemic.

Project description:The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able to optimize the level of policies to stop epidemic growth. We applied this system to study the unfolding of COVID-19 in Bahia, Brazil, also assessing the effects of varying population compliance. We show the importance of finely tuning the levels of enforced measures to achieve SARS-CoV-2 containment, with periodic interventions emerging as an optimal control strategy in the long-term.

| S-EPMC8239053 | biostudies-literature

Efficiency of antiviral treatment in COVID-19.

Project description:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is responsible for generating a global effort to discover urgent therapeutic solutions to limit the human damage caused by COVID-19. In the period of April to June 2020, 105 patients diagnosed with COVID-19 met the conditions for inclusion in the present study. They were treated with antiviral therapy according to local guidelines: D group (53 cases), treated with darunavir/ritonavir (DRV/r); and K group (52 cases), treated with lopinavir/ritonavir (LPV/r). Patients from the K group required 7.5 days of hospitalization less compared to those from the D group (P<0.001). The blood oxygen saturation values recorded in the groups were statistically different [K group (94.02±3.12%) vs. D group (92.13±4.24%), P=0.010]. The percentage of patients with unsatisfactory clinical evolution were non-significantly higher in the D group compared with the K group [20 (37.74%) vs. 12 (23.08%), P=0.157]. We did not note statistically significant differences between the two groups tracked considering the values for the Brescia-COVID Respiratory Severity Scale (BCRSS) of the patients with unsatisfactory clinical evolution, nor of the chest CT' evolution after 10 days of therapy. We did not register significant adverse effects after antiviral therapy in the two groups. Antiviral therapy with LPV/r had some favorable results compared to DRV/r in patients with COVID-19. Both therapies were well tolerated.

| S-EPMC8097236 | biostudies-literature

Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic.

Project description:BackgroundThe worldwide Coronavirus disease 2019 (COVID-19) public health pandemic has restructured clinical care of patients with cancer throughout the world. The specific changes in the management of genitourinary (GU) cancers in different cancer centers owing to COVID-19 are not known, and some clinical scenarios remain controversial. We conducted an opinion survey to determine what changes in cancer treatment strategies are occurring owing to the COVID-19 pandemic.Materials and methodsA 20-item online survey was sent on May 25, 2020 to 170 expert GU medical oncologists from Europe and North America. The survey solicited responses to changes in GU cancer management in the setting of the COVID-19 pandemic. Data was collected and managed via a secure REDCap Database.ResultsSurveys were completed by 78 (45.8%) of 170 GU oncologists between May 25, 2020 and June 25, 2020. Clinical practice changes owing to COVID-19 in at least one scenario were reported by 79.1% of responders, most pronounced in prostate cancer (71.8%) and least pronounced in urothelial cancer (23%). Preferences for change in management varied by country, with 78% (37/47) of United States oncologists indicating a change in their practice, 57% (4/7) of Canadian oncologists, and 79% (19/24) of European oncologists.ConclusionsThis study suggests international practice changes are occurring in GU cancer care during the COVID-19 pandemic. The variability in practice changes between countries may reflect differences in COVID-19 case load during the time point of data collection. These results, based on expert opinion during this rapidly changing crisis, may inform the oncologic community regarding the effects of COVID-19 on GU cancer care.

| S-EPMC7787909 | biostudies-literature

Reinventing European air traffic control based on the covid-19 pandemic experience.

Project description:This article/paper proposes to take advantage of the crisis resulting from COVID-19 and its' impact on Air Traffic Control (ATC) in Europe to reinvent it. The article explains its evolution, in particular, 20 years of Single European Sky reform process not having overcome the gridlock. The impact of the COVID-19 on aviation in general and specifically on ATC is described. It focuses on the avenues to overcome fragmentation and competing interests of the various stakeholders by reinventing EUROCONTROL Organisation as the agent to recover from the economic crisis.

| S-EPMC8755462 | biostudies-literature

Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19)

Project description:To understand and analyse the global impact of COVID-19 on outpatient services, inpatient care, elective surgery, and perioperative colorectal cancer care, a DElayed COloRectal cancer surgery (DECOR-19) survey was conducted in collaboration with numerous international colorectal societies with the objective of obtaining several learning points from the impact of the COVID-19 outbreak on our colorectal cancer patients which will assist us in the ongoing management of our colorectal cancer patients and to provide us safe oncological pathways for future outbreaks.

| 2346925 | ecrin-mdr-crc

Improved treatment adherence and allergic disease control during a COVID-19 pandemic lockdown.

Project description: Not available

| S-EPMC8646784 | biostudies-literature